A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge

Scott G. Hansen, Emily E. Marshall, Daniel Malouli, Abigail B. Ventura, Colette M. Hughes, Emily Ainslie, Julia C. Ford, David Morrow, Roxanne M. Gilbride, Jin Y. Bae, Alfred W. Legasse, Kelli Oswald, Rebecca Shoemaker, Brian Berkemeier, William J. Bosche, Michael Hull, Jennie Womack, Jason Shao, Paul T. Edlefsen, Jason S. ReedBen J. Burwitz, Jonah B. Sacha, Michael K. Axthelm, Klaus Früh, Jeffrey D. Lifson, Louis J. Picker

Research output: Contribution to journalArticlepeer-review

67 Scopus citations

Fingerprint

Dive into the research topics of 'A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge'. Together they form a unique fingerprint.

Medicine & Life Sciences